Pollen Allergy Market Report 2026

The pollen allergy market size has grown strongly in recent years. It will grow from $7.49 billion in 2025 to $8.09 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing prevalence of seasonal allergies, rising environmental pollen exposure, growth in allergy diagnostic services, availability of antihistamine medications, expansion of allergy awareness programs.

The pollen allergy market size is expected to see strong growth in the next few years. It will grow to $10.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to growing adoption of immunotherapy treatments, rising investments in precision allergy diagnostics, increasing focus on preventive allergy care, expansion of biologic allergy treatments, growing integration of digital allergy monitoring tools. Major trends in the forecast period include increasing adoption of personalized allergy therapies, rising use of advanced diagnostic testing for allergens, growing demand for long-term immunotherapy solutions, expansion of seasonal allergy management programs, enhanced focus on early allergy diagnosis.

The increasing prevalence of allergic rhinitis is expected to drive the growth of the pollen allergy market going forward. Allergic rhinitis is an allergic condition that causes inflammation of the nasal passages, leading to symptoms such as sneezing, nasal congestion, and itchy eyes, and is commonly triggered by pollen or dust exposure. The rise in allergic rhinitis is linked to factors including environmental pollution, climate change, urbanization, and lifestyle changes, all of which increase exposure to airborne allergens and pollutants. Pollen allergy is a major cause of allergic rhinitis, as contact with pollen provokes inflammatory responses in the nasal lining. For instance, in October 2023, according to the World Allergy Organization, a US-based umbrella organization for clinical allergy research, allergic rhinitis affects more than 400 million people worldwide, with prevalence ranging from 10% to 30% among adults and exceeding 40% among children. Therefore, the growing prevalence of allergic rhinitis is driving the expansion of the pollen allergy market.

Major companies operating in the pollen allergy market are focusing on the development of comprehensive allergy care platforms that offer integrated solutions for allergy diagnosis, treatment, and long-term management, helping to improve patient outcomes and convenience. A comprehensive allergy care platform for pollen allergy is an integrated system that provides end-to-end support for individuals affected by pollen-related allergies. For instance, in February 2023, Nectar Life Sciences, an India-based pharmaceutical company, launched Nectar, a comprehensive allergy care platform that introduced personalized sublingual immunotherapy drops as its initial offering. These allergy drops are custom formulated based on results from a CLIA-certified at-home allergy test and are designed to address the underlying causes of allergies, offering a convenient alternative to conventional allergy shots and antihistamines. The platform supports treatment through direct-to-home delivery and ongoing prescriptions every three months, enabling individuals with moderate to severe allergies to gradually build tolerance and reduce symptoms over time.

In September 2023, Stallergenes Greer International AG, a Switzerland-based pharmaceutical company, acquired the peanut allergy oral immunotherapy treatment Palforzia from Nestlé S.A. for an undisclosed amount. This acquisition strengthens Stallergenes Greer’s position in the allergen immunotherapy space by expanding its portfolio to include both respiratory and food allergy treatments. Nestlé S.A. is a Switzerland-based food and beverage company with initiatives addressing various allergy types, including food and environmental allergies such as pollen-related conditions.

Major companies operating in the pollen allergy market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd, Genentech Inc., Omega Pharma, ALK Abello, Stallergenes Greer, Aimmune Therapeutics, Allergy Therapeutics, McNeil Consumer Healthcare, Meda Pharmaceuticals Inc, HAL Allergy Group, Allergopharma, Biomay AG, Leti Pharma, Alerpharma S.A.

North America was the largest region in the pollen allergy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pollen allergy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pollen allergy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the pollen allergy market by increasing costs of imported diagnostic reagents, allergy testing instruments, pharmaceutical ingredients, and medical devices used in diagnosis and treatment. Healthcare providers in North America and Europe are most affected due to dependence on imported diagnostic consumables and drug formulations, while Asia-Pacific faces cost pressures on pharmaceutical exports. These tariffs are raising treatment and diagnostic costs and affecting patient access. However, they are also encouraging domestic drug manufacturing, localized production of diagnostic kits, and regional development of allergy treatment solutions.

The pollen allergy market research report is one of a series of new reports that provides pollen allergy market statistics, including pollen allergy industry global market size, regional shares, competitors with a pollen allergy market share, detailed pollen allergy market segments, market trends and opportunities, and any further data you may need to thrive in the pollen allergy industry. This pollen allergy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pollen allergy is an allergic response triggered by pollen from trees, grasses, and weeds. It occurs when the immune system incorrectly perceives pollen as a harmful substance and releases chemicals such as histamine to defend against it. Pollen allergies are typically seasonal, with symptoms peaking in spring, summer, or fall depending on the specific pollen sensitivity of the individual.

The primary product types in the pollen allergy market include instruments, consumables, and services. Instruments include medical devices used for the diagnosis, monitoring, and management of pollen allergies, such as nasal irrigation systems, allergy testing equipment, and inhalers. The types of allergens involved include food allergens, inhaled allergens, drug allergens, and others. Treatment options for pollen allergies consist of antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto injectable epinephrine, and immunotherapy. These products and services are mainly utilized in diagnostic laboratories and hospital settings.

The pollen allergy market consists of sales of nasal sprays, eye drops, allergy masks, air purifiers, and pollen blockers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.